Psilocybin mushrooms (“Magic Mushrooms”)

Selected References:

  • Hallock RM, et al. 2013. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug Alcohol Depend 130(1-3):245-8.
  • Jairaj C, et al. 2022. Postpartum depression: A role for psychedelics? Journal of Psychopharmacology 36(8), 920-931.
  • Rolsten C, 1997. Effects of chlorpromazine and psilocin on pregnancy of C57BL/10 mice and their offspring at birth. Anat Rec 157:311.
  • Stein CA, et al. 2022. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice. J Midwifery Womens Health 67(3):373-383.
  • Timar L, Czeizal AE. 1997, Birth weight and congenital anomalies following poisonous mushroom intoxication during pregnancy. Reprod Toxicol 11: 861.

 

Psilocybin mushrooms (“Magic Mushrooms”)

Selected References:

  • Ackerman S. Discovering the Brain. Washington (DC): National Academies Press (US); 1992. 6. The Development and Shaping of the Brain. Available from: https://www.ncbi.nlm.nih.gov/books/NBK234146/.
  • American College of Obstetricians and Gynecologists (ACOG). 2024. Facts Are Important: Understanding and Navigating Viability. Retrieved from: https://www.acog.org/advocacy/facts-are-important/understanding-and-navigating-viability.
  • Hales B, et al. 2018. Teratology Primer, 3rd Edition. Society for Birth Defects Research and Prevention. https://www.birthdefectsresearch.org/primer/
  • Helwany M, et al. 2023. Embryology, Ear. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557588/
  • Libretti S, Aeddula NR. 2023. Embryology, Genitourinary. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559309/.
  • Malhotra R, et al. 2023. Enhancing Omphalocele Care: Navigating Complications and Innovative Treatment Approaches. Cureus; 15(10):e47638.
  • Moore KL, et al. 2013. The Developing Human: Clinically Oriented Embryology (9th Ed.). Saunders.
  • Rentea RM, Gupta V. 2023. Gastroschisis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557894/.
  • Sadler TW. 2014. Langman’s Medical Embryology (13th Edition), Philadelphia, PA: Wolters Kluwer.
  • Singh R, Munakomi S. Embryology, Neural Tube. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542285/.
  • The Centers for Disease Control and Prevention (CDC). 2024. Specific Birth Defects and Other Health Conditions. Retrieved from: https://www.cdc.gov/birth-defects/about/types.html.
  • Tickle C. 2015. How the embryo makes a limb: determination, polarity and identity. J Anat; 227(4):418-30.
  • Zaontz MR, Packer MG. 1997. Abnormalities of the external genitalia. Pediatr Clin North Am; 44(5):1267-97.

Psilocybin mushrooms (“Magic Mushrooms”)

Selected References

  • Abel MH, et al. 2017. Suboptimal maternal iodine intake is associated with impaired child neurodevelopment at 3 years of age in the Norwegian Mother and Child Cohort Study. J Nutr, 147(7):1314-1324.
  • Alexander EK, et al. 2017. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27(3):315-389.
  • Andersson M, Braegger CP. 2022. The role of iodine for thyroid function in lactating women and infants. Endocr Rev, 43(3):469-506.
  • Council on Environmental Health.   Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem.  Pediatrics, 133:1163-1166.
  • Hamby T, et al. 2018. Maternal iodine excess: an uncommon cause of acquired neonatal hypothyroidism. J Pediatr Endocrinol Metab, 31(9):1061-1064.
  • Kerver JM, et al. 2021. Prevalence of inadequate and excessive iodine intake in a US pregnancy cohort. Am J Obstet Gynecol, 224(1):82.e1-82.e8.
  • Leung AM, et al. 2009. Iodine content of prenatal multivitamins in the United States. N Engl J Med, 360(9):939-940.
  • Melse-Boonstra A, Mackenzie I. 2013. Iodine deficiency, thyroid function and hearing deficit: a review. Nutr Res Rev, 26(2):110-117.
  • Næss S, et al. 2023. Infant iodine status and associations with maternal iodine nutrition, breast-feeding status and thyroid function. The British journal of nutrition, 129(5):854–863.
  • Obican SG, et al. 2012. Teratology public affairs committee position paper: Iodine deficiency in pregnancy. Birth Defects Res A Clin Mol Teratol, 94(9):677-82.
  • Partal-Lorente AB, et al. 2017. Iodine is associated to semen quality in men who undergo consultations for infertility. Reprod Toxicol, 73:1-7.
  • Pawlak R, et al. 2023. Prevalence and predictors of low breast milk iodine concentration in women following vegan, vegetarian, and omnivore diets. Breastfeeding Medicine 18(1):37-42.
  • Pérez-López FR. 2007. Iodine and thyroid hormones during pregnancy and postpartum. Gynecol Endocrinol, 23(7):414-428.
  • Petersen E, et al. 2020. Iodine status of breastfed infants and their mothers’ breast milk iodine concentration. Matern Child Nutr, 16(3):e12993.
  • Purdue-Smithe AC, et al. 2022. Iodine and thyroid status during pregnancy and risk of stillbirth: A population-based nested case-control study. Matern Child Nutr, 18(1):e13252.
  • Soldin OP, et al. 2003. Urinary iodine percentile ranges in the United States. Clin Chim Acta, 328(1-2):185-90.
  • Thomas Jde V, Collett-Solberg PF. 2009. Perinatal goiter with increased iodine uptake and hypothyroidism due to excess maternal iodine ingestion. Horm Res, 72(6):344-7.
  • Yang J, et al. 2017. Maternal iodine status during lactation and infant weight and length in Henan Province, China. BMC Pregnancy Childbirth. 17(1):383.
  • Zhao W, et al. 2019. Iodine nutrition during pregnancy. Biol Trace Elem Res, 188(1): 196-207.
  • Zimmermann MB. 2007. The impact of iodized salt or iodine supplements on iodine status during pregnancy, lactation and infancy. Public Health Nutr, 10(12A):1584-1595.

 

 

Psilocybin mushrooms (“Magic Mushrooms”)

Selected References:

  • Amber MR, et al. 2015. Safety of popular herbal supplements in lactating women. J Hum Lact, 31(3):348-353.
  • Ashar BH and Rowland-Seymour A. 2008. Advising patients who use dietary supplements. Am J Med, 121(2):91-97.
  • Balbontin YM, et al. 2019. Herbal medicinal product use during pregnancy and the postnatal period. Obstetrics and gynecology, 133(5):920-932.
  • Bruno LO et al. 2018. Pregnancy and herbal medicines: an unnecessary risk for women’s health. Phytotherapy Research, 32(5):796-810.
  • Ciganda C and Laborde A. 2003. Herbal infusions used for induced abortion. J Toxicol Clin Toxicol, 41(3):235-239.
  • Dante G, et al. 2013. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Maternal-Fetal and Neonatal Med, 26(3): 306-312.
  • Dante G et al. 2014. Herbal therapies in pregnancy: what works? Curr Opin Obstet Gynecol, 26:83-91.
  • Frawley J et al. 2015. Women’s use and self-prescription of herbal medicine during pregnancy: an examination of 1,835 pregnant women. Women’s Health Issues, 25(4):396-402.
  • Kim KH, et al. 2018. Characteristics and outcomes of female infertility treatment programs using traditional medicine in Korea: a multisite analysis. J Alternative and Complimentary Medicine, 24(6):570-577.
  • Lei HL, et al. 2015. Relationship between risk factors for infertility in women and lead, cadmium, and arsenic blood levels: a cross-sectional study from Taiwan. BMC Public Health, 15:1220.
  • Newmaster SG, et al. 2013. DNA Barcoding detects contamination and substitution in North American herbal products. BMC Medicine, 11:222.
  • Smeriglio A, et al. 2014. Herbal products in pregnancy: experimental studies and clinical reports. Phytother Res, 28:1107-1116.
  • Trabace L, et al. 2015. “Natural” relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm. J Ethnopharmacol 174:396-402.
  • Wang CC, et al. 2013. Pregnancy outcomes, embryonic and fetal development in maternal exposure to Chinese medicines. Birth Defects Res (Part C), 99:275-291.
  • Zamawe C, et al. 2018. Effectiveness and safety of herbal medicines for induction of labour: a systematic review and meta-analysis. BMJ Open. 9(10):1-9.

Psilocybin mushrooms (“Magic Mushrooms”)

Selected References  

  • Bernigaud C, et al. 2020. The Management of Scabies in the 21 st Century: Past, Advances and Potentials. Acta dermato-venereologica, 100. 
  • Bowden VR. 2012. Losing the louse: how to manage this common infestation in children. Pediatr Nurs, 38(5):253- 254, 277.  
  • Chan R & Hoyt-Austin AE. 2024. Scabies Infection While Expressing Human Milk for Critically Ill Infants: Is It Safe?. Breastfeeding medicine: the official journal of the Academy of Breastfeeding Medicine, 19(4):306–308. 
  • Cole SW, et al. 2011. Spinosad for treatment of head lice infestation. Pharmacother 45.7-8: 954-959.Clin Infect Dis. (2002) 35 (Supplement 2): S146-S151.  
  • Dzierzawski A. 1977. Embryo-toxicity studies of lindane in the golden hamster, rat and rabbit. Bull Vet Inst Pulawy, 21:85-93.  
  • Gunning K, et al. 2019. Lice and Scabies: Treatment Update. Am Fam Physician, 99(10):635-642.  
  • Gupta P. 1990. Teratogenic effects of cypermethrin in rats. J Environ Biol, 11(2):121-126.  
  • Hale, T. 2006. Medications and Mothers’ Milk. Amarillo, TX: Hale Publishing.  
  • Kennedy D, et al. 2005. Pregnancy outcome following exposure to permethrin and use of teratogen information. Am J Perinatol, 22(2):87-90.  
  • Khera K, et al. 1982. Teratogenicity study on pyrethrum and rotenone (natural origin) in pregnant rats. J Toxicol Environ Health, 10:111-119.  
  • Khera K, et al. 1978 Teratogenicity studies on linuron, malathion, and methoxychlor in rats. Toxicol Appl Pharmacol, 45:435-444.  
  • Leachman SA, et al. 2006. The use of dermatologic drugs in pregnancy and lactation. Derm clin, 24.2:167-197. 
  • Miyamoto J. 1976 Degradation, metabolism and toxicity of synthetic pyrethroids. Environ Health Criter, 14:15-28.  
  • Morand A, et al. 2024. Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology. The British journal of dermatology, 191(6):1014–1016. 
  • Murase JE, et al. 2014. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Amer Aca of Derm, 70:401-e1. 
  • Mytton OT, et al. 2007. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG, 114(5):582-587.  
  • Nicolas P, et al. 2020. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health, 8:e92–e100. 
  • Ogbuokiri J, et al. 1994. Ivermectin levels in human breast milk [letter]. Eur J Clin Pharmacol, 46:89-90.  
  • Pacque M, et al. 1990. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. The Lancet, 336.8729:1486-1489. 
  • Patel VM, et al. 2016. Safety of topical medications for scabies and lice in pregnancy. Ind J of Derm, 61(6): 583. 
  • Porto I. 2003. Antiparasitic drugs & lactation: focus on anthelmintics, scabicides, & pediculosis. J Hum Lact, 19:421-5. 
  • Rosumeck S, et al. 2018. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev 4 
  • Salavastru CM, et al. 2017. European guideline for the management of scabies. J Eur Acad Dermatol Venereol JEADV, 31:1248–1253.  
  • Sánchez-Díaz M, et al. 2024. European survey on the management of scabies by dermatologists in children under 2 months, pregnancy and breastfeeding woman. Journal of the European Academy of Dermatology and Venereology, 38(11):e950–e953.  
  • Sciammarella J. Scabies. Retrieved November 2014 from: http://www.emedicine.com/EMERG/topic517.htm.   
  • Strong M, et al. 2007.  Interventions for treating scabies. Cochrane Database Syst Rev, 3.   
  • Sunderkötter C, et al. 2021. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int, 118(41):695-704. PMID: 34615594 PMCID: PMC8743988 DOI: 10.3238/arztebl.m2021.0296   
  • The Centers for Disease Control and Prevention (CDC). 2019. Parasites –Lice – Treatment. [Accessed 4/2021]. Available at URL: https://www.cdc.gov/parasites/lice/head/treatment.html   
  • The Centers for Disease Control and Prevention (CDC). 2019. Parasites –Scabies -Medication. [Accessed 4/2021]. Available at URL: https://www.cdc.gov/parasites/scabies/health_professionals/meds.html   
  • The Centers for Disease Control and Prevention (CDC). 2010. Parasites–Scabies. Available at URL: https://www.cdc.gov/parasites/scabies/index.html [Accessed 5/2023].  
  • Weill A et al. 2021. Scabies-infested pregnant women: A critical therapeutic challenge. PLOS Neglected Trop Dis, 15.1: e0008929. 

                                                  

Psilocybin mushrooms (“Magic Mushrooms”)
1 أبريل، 2025		 صفحة {PAGENO} من {PAGETOTAL}